Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hugh R Barrett

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 11, 2014
Effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial stateAnnette T Y Wong, Dick C Chan, P Hugh R Barrett, et al.
Diabetes Care|February 27, 2010
Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss dietDick C Chan, Gerald F Watts, Seng Khee Gan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2018
Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein MetabolismDick C Chan, Gerald F Watts, Ransi Somaratne, et al.
Diabetes Care|August 10, 2007
Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levelsTheodore W K Ng, Gerald F Watts, P Hugh R Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2011
Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesityEsther M M Ooi, Gerald F Watts, Dennis L Sprecher, et al.
The Journal of Clinical Endocrinology and Metabolism|November 22, 2007
Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndromeEsther M M Ooi, Gerald F Watts, Paul J Nestel, et al.
Journal of the American Heart Association|March 23, 2019
Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering TherapyDick C Chan, Gerald F Watts, Blai Coll, et al.
Journal of Lipid Research|August 30, 2012
Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndromeEsther M M Ooi, Theodore W K Ng, Gerald F Watts, et al.
Journal of Lipid Research|April 24, 2010
Effect of apolipoprotein E genotype on apolipoprotein B-100 metabolism in normolipidemic and hyperlipidemic subjectsEsther M M Ooi, Edward D Janus, Susan J Grant, et al.
Journal of Lipid Research|February 28, 2002
Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteinsKevin P Dwyer, P Hugh R Barrett, Dick Chan, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|March 11, 2014
Effect of ω-3 fatty acid ethyl esters on apolipoprotein B-48 kinetics in obese subjects on a weight-loss diet: a new tracer kinetic study in the postprandial stateAnnette T Y Wong, Dick C Chan, P Hugh R Barrett, et al.
Diabetes Care|February 27, 2010
Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss dietDick C Chan, Gerald F Watts, Seng Khee Gan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2018
Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein MetabolismDick C Chan, Gerald F Watts, Ransi Somaratne, et al.
Diabetes Care|August 10, 2007
Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levelsTheodore W K Ng, Gerald F Watts, P Hugh R Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2011
Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesityEsther M M Ooi, Gerald F Watts, Dennis L Sprecher, et al.
The Journal of Clinical Endocrinology and Metabolism|November 22, 2007
Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndromeEsther M M Ooi, Gerald F Watts, Paul J Nestel, et al.
Journal of the American Heart Association|March 23, 2019
Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol-Lowering TherapyDick C Chan, Gerald F Watts, Blai Coll, et al.
Journal of Lipid Research|August 30, 2012
Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndromeEsther M M Ooi, Theodore W K Ng, Gerald F Watts, et al.
Journal of Lipid Research|April 24, 2010
Effect of apolipoprotein E genotype on apolipoprotein B-100 metabolism in normolipidemic and hyperlipidemic subjectsEsther M M Ooi, Edward D Janus, Susan J Grant, et al.
Journal of Lipid Research|February 28, 2002
Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteinsKevin P Dwyer, P Hugh R Barrett, Dick Chan, et al.
Pageof 15